| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.VETIMM.2012.01.006 |
| P698 | PubMed publication ID | 22293625 |
| P2093 | author name string | S W Dow | |
| L Mitchell | |||
| J E Slansky | |||
| B J Biller | |||
| P2860 | cites work | New CFSE-based assay to determine susceptibility to lysis by cytotoxic T cells of leukemic precursor cells within a heterogeneous target cell population | Q28186126 |
| Immunosuppressive networks in the tumour environment and their therapeutic relevance | Q29619244 | ||
| Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer | Q29620068 | ||
| Immunophenotypic features of tumor infiltrating lymphocytes from mammary carcinomas in female dogs associated with prognostic factors and survival rates | Q33595267 | ||
| Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy | Q34681370 | ||
| Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma | Q35849633 | ||
| Response evaluation criteria for peripheral nodal lymphoma in dogs (v1.0)--a Veterinary Cooperative Oncology Group (VCOG) consensus document | Q37709533 | ||
| Virus-specific cytotoxic CD4+ T cells for the treatment of EBV-related tumors | Q39715560 | ||
| Suppression of antitumor immunity by IL-10 and TGF-beta-producing T cells infiltrating the growing tumor: influence of tumor environment on the induction of CD4+ and CD8+ regulatory T cells | Q40259678 | ||
| Decreased ratio of CD8+ T cells to regulatory T cells associated with decreased survival in dogs with osteosarcoma. | Q43052209 | ||
| Pivotal role of innate and adaptive immunity in anthracycline chemotherapy of established tumors | Q43546471 | ||
| Use of FoxP3 expression to identify regulatory T cells in healthy dogs and dogs with cancer | Q44194874 | ||
| Induction of tumor cell apoptosis in vivo increases tumor antigen cross-presentation, cross-priming rather than cross-tolerizing host tumor-specific CD8 T cells | Q44432115 | ||
| Cd4+ T-cell immune response to large B-cell non-Hodgkin's lymphoma predicts patient outcome. | Q53329309 | ||
| Prognostic significance of tumour-infiltrating T lymphocytes and T-cell subsets in de novo diffuse large B-cell lymphoma: a multiparameter flow cytometry study | Q73740958 | ||
| Lymphocyte subsets in peripheral blood of dogs--a flow cytometric study | Q74514000 | ||
| Regulatory T-cell development: is Foxp3 the decider? | Q79888469 | ||
| Effects of chemotherapy on immune responses in dogs with cancer | Q83085365 | ||
| Flow cytometric analysis of peripheral blood and tumor-infiltrating regulatory T cells in dogs with oral malignant melanoma | Q84189316 | ||
| P433 | issue | 3-4 | |
| P304 | page(s) | 597-603 | |
| P577 | publication date | 2012-01-14 | |
| P1433 | published in | Veterinary Immunology and Immunopathology | Q7923704 |
| P1476 | title | Induction of remission results in spontaneous enhancement of anti-tumor cytotoxic T-lymphocyte activity in dogs with B cell lymphoma | |
| P478 | volume | 145 |
| Q30239893 | Canine cancer immunotherapy studies: linking mouse and human |
| Q34041661 | Dissecting the regulatory microenvironment of a large animal model of non-Hodgkin lymphoma: evidence of a negative prognostic impact of FOXP3+ T cells in canine B cell lymphoma |
| Q37101956 | Safety and efficacy of a genetic vaccine targeting telomerase plus chemotherapy for the therapy of canine B-cell lymphoma |
| Q59350793 | The canine MHC class Ia allele DLA-88*508:01 presents diverse self- and canine distemper virus-origin peptides of varying length that have a conserved binding motif |
Search more.